Blood clots and vaccine supply on the agenda
• There are ongoing issues with COVID vaccinations and blood clots, with US regulators recommending a suspension in the use of the Johnson & Johnson vaccine. Six cases in 6.8 million doses have been reported, and officials are investigating. Yesterday, Australia recorded the 2nd case of blood clots likely linked to the AstraZeneca vaccine. After 700,000 doses of that vaccine have been administered in Oz, 2 cases of blood clots have been reported. “Your chances of winning lotto are much, much higher,” regulator John Skerritt said.
• Issues too for Novavax – one of the vaccines Australia has contracted – it’s experiencing manufacturing delays. Yet to go through the approval process here, it was hoped the US-made vaccine would boost our program in the middle of this year – that could now be pushed later.
• And you know what our vaccination program problems need? More meetings… There’s no new timetable for vaccinating Aussies, but PM Morrison is putting National Cabinet on a “war-footing” by pulling state/territory leaders together twice a week to focus on “making our vaccination program as good as it can be”. That kicks off on Monday.
Know someone who'd be interested in this story? Click to share...
The Squiz Today
Your shortcut to being informed, we've got your news needs covered.
Also Making News
Get the Squiz Today newsletter
Quick, agenda-free news that doesn't take itself too seriously. Get on it.